Clinical Trial Update: CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating consolidation with CD45RA-depleted CD19-CAR T cells after haploidentical hematopoietic cell transplantation in relapsed/refractory CD…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Hematologic Malignancy
• Lymphoma

Drugs mentioned

• CD19 CAR T cells (CD45RA-depleted)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Relapsed Pediatric ALL, Hematopoietic Cell Transplantation | Phase 1 | Status: RECRUITING